Editas Medicine, Inc.
CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS
Last updated:
Abstract:
CRISPR/CAS-related compositions and methods for treatment of Cystic Fibrosis (CF).
Status:
Application
Type:
Utility
Filling date:
30 Apr 2021
Issue date:
9 Dec 2021